150 related articles for article (PubMed ID: 33238867)
1. An Overview of Targeting Legumain for Inhibiting Cancers.
Reddy BD; Beeraka NM; Chitturi CMK; Madhunapantula SV
Curr Pharm Des; 2021 Oct; 27(31):3337-3348. PubMed ID: 33238867
[TBL] [Abstract][Full Text] [Related]
2. Role of LGMN in tumor development and its progression and connection with the tumor microenvironment.
Khan SU; Khan IM; Khan MU; Ud Din MA; Khan MZ; Khan NM; Liu Y
Front Mol Biosci; 2023; 10():1121964. PubMed ID: 36825203
[TBL] [Abstract][Full Text] [Related]
3. Legumain Promotes Gastric Cancer Progression Through Tumor-associated Macrophages
Wang H; Chen B; Lin Y; Zhou Y; Li X
Int J Biol Sci; 2020; 16(1):172-180. PubMed ID: 31892854
[TBL] [Abstract][Full Text] [Related]
4. Targeting Legumain As a Novel Therapeutic Strategy in Cancers.
Mai CW; Chung FF; Leong CO
Curr Drug Targets; 2017; 18(11):1259-1268. PubMed ID: 27993111
[TBL] [Abstract][Full Text] [Related]
5. Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2.
Tu NH; Jensen DD; Anderson BM; Chen E; Jimenez-Vargas NN; Scheff NN; Inoue K; Tran HD; Dolan JC; Meek TA; Hollenberg MD; Liu CZ; Vanner SJ; Janal MN; Bunnett NW; Edgington-Mitchell LE; Schmidt BL
J Neurosci; 2021 Jan; 41(1):193-210. PubMed ID: 33172978
[TBL] [Abstract][Full Text] [Related]
6. TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
D'Costa ZC; Higgins C; Ong CW; Irwin GW; Boyle D; McArt DG; McCloskey K; Buckley NE; Crawford NT; Thiagarajan L; Murray JT; Kennedy RD; Mulligan KA; Harkin DP; Waugh DJ; Scott CJ; Salto-Tellez M; Williams R; Mullan PB
Oncotarget; 2014 Mar; 5(6):1609-20. PubMed ID: 24742492
[TBL] [Abstract][Full Text] [Related]
7. Nucleoplasmic calcium regulates cell proliferation through legumain.
Andrade V; Guerra M; Jardim C; Melo F; Silva W; Ortega JM; Robert M; Nathanson MH; Leite F
J Hepatol; 2011 Sep; 55(3):626-635. PubMed ID: 21237226
[TBL] [Abstract][Full Text] [Related]
8. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis.
Lewēn S; Zhou H; Hu HD; Cheng T; Markowitz D; Reisfeld RA; Xiang R; Luo Y
Cancer Immunol Immunother; 2008 Apr; 57(4):507-15. PubMed ID: 17786443
[TBL] [Abstract][Full Text] [Related]
9. MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain.
Zhang Y; Wu YY; Jiang JN; Liu XS; Ji FJ; Fang XD
Oncotarget; 2016 Dec; 7(50):83223-83230. PubMed ID: 27793040
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA circLGMN facilitates glioblastoma progression by targeting miR-127-3p/LGMN axis.
Chen B; Wang M; Huang R; Liao K; Wang T; Yang R; Zhang W; Shi Z; Ren L; Lv Q; Ma C; Lin Y; Qiu Y
Cancer Lett; 2021 Dec; 522():225-237. PubMed ID: 34582975
[TBL] [Abstract][Full Text] [Related]
11. Autocrine pro-legumain promotes breast cancer metastasis via binding to integrin αvβ3.
Liu C; Wang J; Zheng Y; Zhu Y; Zhou Z; Liu Z; Lin C; Wan Y; Wen Y; Liu C; Yuan M; Zeng YA; Yan Z; Ge G; Chen J
Oncogene; 2022 Aug; 41(34):4091-4103. PubMed ID: 35854065
[TBL] [Abstract][Full Text] [Related]
12. The extracellular vesicular pseudogene LGMNP1 induces M2-like macrophage polarization by upregulating LGMN and serves as a novel promising predictive biomarker for ovarian endometriosis recurrence.
Sun SG; Guo JJ; Qu XY; Tang XY; Lin YY; Hua KQ; Qiu JJ
Hum Reprod; 2022 Mar; 37(3):447-465. PubMed ID: 34893848
[TBL] [Abstract][Full Text] [Related]
13. Legumain affects the PI3K/AKT tumor progression pathway in retinoblastoma.
Tang Q; Xu F; Lin J; Zhang C; Liu X; Dong L; Zhao J; Zhu L; Lin T
Exp Eye Res; 2022 Nov; 224():109221. PubMed ID: 36041510
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-Derived Legumain Promotes Pulmonary Hypertension by Activating the MMP (Matrix Metalloproteinase)-2/TGF (Transforming Growth Factor)-β1 Signaling.
Bai P; Lyu L; Yu T; Zuo C; Fu J; He Y; Wan Q; Wan N; Jia D; Lyu A
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):e130-e145. PubMed ID: 30676070
[TBL] [Abstract][Full Text] [Related]
15. Asparaginyl Endopeptidase (Legumain) Supports Human Th1 Induction via Cathepsin L-Mediated Intracellular C3 Activation.
Freeley S; Cardone J; Günther SC; West EE; Reinheckel T; Watts C; Kemper C; Kolev MV
Front Immunol; 2018; 9():2449. PubMed ID: 30405635
[TBL] [Abstract][Full Text] [Related]
16. The LGMN pseudogene promotes tumor progression by acting as a miR-495-3p sponge in glioblastoma.
Liao K; Qian Z; Zhang S; Chen B; Li Z; Huang R; Cheng L; Wang T; Yang R; Lan J; Lu X; Kong L; Song X; Qiu Y; Lin Y
Cancer Lett; 2020 Oct; 490():111-123. PubMed ID: 32711096
[TBL] [Abstract][Full Text] [Related]
17. Legumain: a potential biomarker for atherosclerosis.
Ke BY; Qin YS; Cheng L; Wang SZ
J Pharm Pharmacol; 2023 Nov; 75(11):1395-1404. PubMed ID: 37584490
[TBL] [Abstract][Full Text] [Related]
18. Pigmented Microbial Extract (PMB) from
Bandi DR; Chitturi CMK; Aswathanarayan JB; Veeresh PKM; Bovilla VR; Sukocheva OA; Devi PS; Natraj SM; Madhunapantula SV
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139241
[TBL] [Abstract][Full Text] [Related]
19. Network-based identification of miRNAs and transcription factors and
Iqbal S; Malik MZ; Pal D
Heliyon; 2021 Dec; 7(12):e08502. PubMed ID: 34917801
[TBL] [Abstract][Full Text] [Related]
20. The Cysteine Protease Legumain Is Upregulated by Vitamin D and Is a Regulator of Vitamin D Metabolism in Mice.
Forbord KM; Okla M; Lunde NN; Bosnjak-Olsen T; Arnekleiv G; Hesselson D; Johansen HT; Tang JCY; Kassem M; Solberg R; Jafari A
Cells; 2023 Dec; 13(1):. PubMed ID: 38201240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
